co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Vaccines save millions of lives, but myths and misconceptions about their necessity remain even in urban, educated communities. As a result, misconceptions are often leading to delay in vaccination, putting everyone at risk of preventable disease. Dispelling these myths is important to make informed and science-based health decisions.
"State health minister Prakash Abitkar informed me that cancer cases are increasing and that a new (HPV) vaccine is available. We are positively considering making this vaccine available for girls in the state," he said.
Did you know 1 in every 4 Indian men is affected by HPV. Know more about it from Dr. Dhwani Mago, Obstetrician & Gynaecologist. Watch the full interview here!
Maintaining a regular periodic check on your health helps. And while vaccines do not offer foolproof protection from any disease, they better the ability of a relatively healthy body to combat diseases.
The NTAGI recommendation was based on fresh evidence on disease burden, evidence on the effectiveness of a single dose of HPV vaccine, clinical trial data and experience of the Government of Sikkim on the introduction of the vaccine, it stated.
The introduction and nationwide scale-up is planned in a phased manner over a period of three to four years subject to the availability of sufficient vaccine doses, MoS Health Bharati Pravin Pawar said.
Serum Institute's made-in-India HPV vaccine "CERVAVAC" was launched by Union Home Minister Amit Shah on January 24, in presence of the Pune-based firm's CEO Adar Poonawalla and Prakash Kumar Singh, its Director-Government and Regulatory Affairs.
Exports will have to wait till 2024, its chief executive Adar Poonawalla told reporters here on Thursday evening, adding that the company has to build a scale of manufacturing to over 150 million for that.
Prakash Kumar Singh, Director, Government and Regulatory Affairs, Serum Institute of India (SII) has written to the Union health ministry, confirming the supply of 1 crore doses of qHPV by December, 2022 under the National Vaccination Programme.
